DariaYu Chernysheva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
DariaYu Chernysheva has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Sergey V. Popov
St. Luka’s Clinical Hospital; S. M. Kirov Military Medical Academy, Russian Ministry of Defense of Russia; St. Petersburg Medical and Social Institute
9 shared publications - Igor N. Orlov
St. Luke’s Saint Petersburg Clinical Hospital; Mechnikov North-Western State Medical University
8 shared publications - Timur M. Topuzov
St. Luke's Clinical Hospital, St. Petersburg
5 shared publications - Aleksey Olegovich Tsoy
Clinical Hospital of St. Luke
4 shared publications - Sergey M. Malevich
St. Luke Clinical Hospital
4 shared publications - V. A. Neradovskiy
St. Luka's Clinical Hospital
3 shared publications
Latest Publications
- Open Access
European Registry of Next Generation Imaging in Advanced Prostate Cancer (RING): protocol for an international, prospective registry study
Introduction: Next-generation imaging (NGI), particularly with prostate-specific membrane antigen positron emission tomography (PSMA PET) tracers, enables earlier and more accurate detection of metastases. However, conventional imaging (CT and bone scan) remains more affordable and widely accessible and was the standard used in most pivotal trials that established current survival outcomes. As PSMA PET becomes more widely adopted, a stage migration effect is emerging. However, key uncertainties persist regarding the actual proportional employment of NGI in clinical practice, main indications for its use and the mid-term and long-term effects of an NGI-driven treatment pathway. Furthermore, when or whether CI alone might remain enough informative for the treatment decision-making is still unclear. Methods and analysis: The European Registry of Next-Generation Imaging in Advanced Prostate Cancer is a non-profit, non-interventional, multi-centre, international, prospective, investigator-initiated registry that is intended to collect real-world data on how patients with prostate cancer at risk of harbouring metastasis (high-risk at initial diagnosis, or after primary treatment) are managed according to the type of imaging used for the systemic work-up. The registry is conducted in two phases: (1) cross-sectional analysis of imaging choices and their effect on clinical decision-making and (2) longitudinal follow-up evaluating survival outcomes such as progression-free survival (PFS), disease-specific survival (DSS) and skeletal-related events (SSEs). Statistical analyses will include descriptive analysis of demographic and clinical variables, comparative analysis between different imaging pathways, survival and prognostic analyses using Kaplan–Meier tests. The expected minimum sample size of the registry is 600 patients, and the planned follow-up duration is 24 months for the longitudinal follow-up. Ethics and dissemination: The study protocol was approved by the ethics committee of Fundació Puigvert (#C2024/30), and ethics approval is required at all participating sites. All patients will provide written informed consent. The results will be disseminated widely and transparently to maximise their effect on clinical practice, research and patient care through peer-reviewed publications, presentations at international conferences as well as through patient advocacy groups and relevant patient websites. Trial registration number: NCT06866782 .
Open AccessEuropean Registry of Next Generation Imaging in Advanced Prostate Cancer (RING): protocol for an international, prospective registry study
Introduction: Next-generation imaging (NGI), particularly with prostate-specific membrane antigen positron emission tomography (PSMA PET) tracers, enables earlier and more accurate detection of metastases. However, conventional imaging (CT and bone scan) remains more affordable and widely accessible and was the standard used in most pivotal trials that established current survival outcomes. As PSMA PET becomes more widely adopted, a stage migration effect is emerging. However, key uncertainties persist regarding the actual proportional employment of NGI in clinical practice, main indications for its use and the mid-term and long-term effects of an NGI-driven treatment pathway. Furthermore, when or whether CI alone might remain enough informative for the treatment decision-making is still unclear. Methods and analysis: The European Registry of Next-Generation Imaging in Advanced Prostate Cancer is a non-profit, non-interventional, multi-centre, international, prospective, investigator-initiated registry that is intended to collect real-world data on how patients with prostate cancer at risk of harbouring metastasis (high-risk at initial diagnosis, or after primary treatment) are managed according to the type of imaging used for the systemic work-up. The registry is conducted in two phases: (1) cross-sectional analysis of imaging choices and their effect on clinical decision-making and (2) longitudinal follow-up evaluating survival outcomes such as progression-free survival (PFS), disease-specific survival (DSS) and skeletal-related events (SSEs). Statistical analyses will include descriptive analysis of demographic and clinical variables, comparative analysis between different imaging pathways, survival and prognostic analyses using Kaplan–Meier tests. The expected minimum sample size of the registry is 600 patients, and the planned follow-up duration is 24 months for the longitudinal follow-up. Ethics and dissemination: The study protocol was approved by the ethics committee of Fundació Puigvert (#C2024/30), and ethics approval is required at all participating sites. All patients will provide written informed consent. The results will be disseminated widely and transparently to maximise their effect on clinical practice, research and patient care through peer-reviewed publications, presentations at international conferences as well as through patient advocacy groups and relevant patient websites. Trial registration number: NCT06866782 .
- Open Access
- 1 October 2022
- Published by Rostov State Medical University in Urology Herald
- Vol. 10 (3) , 145-150
Giant penile melanoma
Primary penile melanoma is an extremely rare casuistic pathology associated with a poor prognosis. The article presents a clinical case of massive lesion of the penis with malignant melanoma, and discusses surgical methods for treating this pathology.
- 1 October 2022
- Published by Rostov State Medical University in Urology Herald
- Vol. 10 (3) , 145-150
Open AccessGiant penile melanoma
Primary penile melanoma is an extremely rare casuistic pathology associated with a poor prognosis. The article presents a clinical case of massive lesion of the penis with malignant melanoma, and discusses surgical methods for treating this pathology.
- Open Access
- 30 March 2022
- Published by Rostov State Medical University in Urology Herald
- Vol. 10 (1) , 52-59
YV-plasty in the treatment of patients with recurrent bladder neck stenosis
Introduction. Bladder neck stenosis (BNS) is a late complication of surgical treatment for benign prostatic hyperplasia. Available methods of endoscopic correction in primary BNS have limited effectiveness, while in recurrent cases their use does not lead to satisfactory results at all. YV-plasty of the bladder neck (BN) is one of the available methods of treatment for recurrent BNS.Purpose of the study. To evaluate the treatment results of patients with recurrent BNS using endovideoscopic YV-plasty of the BN.Materials and methods. We retrospectively analyzed the treatment results of 8 patients with recurrent BNS who underwent endovideoscopic YV-plasty of the BN in the Urology Division No.1 of the St. Luke St. Petersburg Clinical Hospital from 2019 to 2021.Results. Endovideoscopic YV-plasty of the bladder neck was successfully performed in all 8 patients. The mean preoperative Qmax was 3.7 ml/s (1.8 – 5.7). At 6 months after surgery, the mean Qmax was 21.4 mL/s (16.7 – 24.1). The mean preoperative I-PSS score was 20.5 (17 – 24). The mean I-PSS score 6 months after surgery was 7.1 (5.0 – 9.0). No cases of de-novo stress urinary incontinence were registered.Conclusions. Endovideoscopic YV-plasty of the BN may be an effective and safe method of treatment of patients with recurrent BNS. However, further studies are needed to obtain long-term results.
- 30 March 2022
- Published by Rostov State Medical University in Urology Herald
- Vol. 10 (1) , 52-59
Open AccessYV-plasty in the treatment of patients with recurrent bladder neck stenosis
Introduction. Bladder neck stenosis (BNS) is a late complication of surgical treatment for benign prostatic hyperplasia. Available methods of endoscopic correction in primary BNS have limited effectiveness, while in recurrent cases their use does not lead to satisfactory results at all. YV-plasty of the bladder neck (BN) is one of the available methods of treatment for recurrent BNS.Purpose of the study. To evaluate the treatment results of patients with recurrent BNS using endovideoscopic YV-plasty of the BN.Materials and methods. We retrospectively analyzed the treatment results of 8 patients with recurrent BNS who underwent endovideoscopic YV-plasty of the BN in the Urology Division No.1 of the St. Luke St. Petersburg Clinical Hospital from 2019 to 2021.Results. Endovideoscopic YV-plasty of the bladder neck was successfully performed in all 8 patients. The mean preoperative Qmax was 3.7 ml/s (1.8 – 5.7). At 6 months after surgery, the mean Qmax was 21.4 mL/s (16.7 – 24.1). The mean preoperative I-PSS score was 20.5 (17 – 24). The mean I-PSS score 6 months after surgery was 7.1 (5.0 – 9.0). No cases of de-novo stress urinary incontinence were registered.Conclusions. Endovideoscopic YV-plasty of the BN may be an effective and safe method of treatment of patients with recurrent BNS. However, further studies are needed to obtain long-term results.
- 2 November 2021
- Published by Bionika Media in Urologiia
- Vol. 5_2021 (5) , 105-110
Ultrasound-based techniques of targeted prostate biopsy
The article is devoted to the multiparametric ultrasound techniques for prostate biopsy targeting. This literature review illustrates the variety of ultrasound-based targeting procedures and presents data concerning the diagnostic value of each. A special attention is given to every targeted technique limitations and the opportunity for the MTI-fusion.
- 2 November 2021
- Published by Bionika Media in Urologiia
- Vol. 5_2021 (5) , 105-110
Ultrasound-based techniques of targeted prostate biopsy
The article is devoted to the multiparametric ultrasound techniques for prostate biopsy targeting. This literature review illustrates the variety of ultrasound-based targeting procedures and presents data concerning the diagnostic value of each. A special attention is given to every targeted technique limitations and the opportunity for the MTI-fusion.
- Open Access
- 25 September 2021
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 14 (3)
Options for antibacterial prophylaxis of infectious complications of prostate biopsy
Introduction. Amount of prostate biopsy procedures rises every year and up to 95% of cases of prostate biopsy is performed via transrectal approach. The incidence of infectious complications of transrectal prostate biopsy reaches up to 17%, while incidence of such complications of transperineal biopsy is about 1%. The majority of international clinical guidelines recommends for obligatory antibiotic prophylaxis prior to prostate biopsy of any approach, but the choice of antibiotic is still debatable. The aim of this review is to sum up the approaches of international urological guidelines to the antibiotic prophylaxis prior to prostate biopsy. Materials and methods. We analyzed the search results in the scientific databases PubMed, Google Scolar, elibrary.ru for the queries «prostate biopsy», «antibacterial prophylaxis» and «guidelines». Results. According to the recommendations of most professional communities, antibacterial prophylaxis of infectious complications of prostate biopsy can be carried out in various ways - once or for a long time, one- or two-component, empirically or on the basis of urine culture on microflora. Conclusion. Despite the differences in the levels of sensitivity and resistance of coliform flora around the world, the clinical guidelines in most countries are uniform in terms of the choice of drugs to reduce the risk of developing infectious complications after prostate biopsy. Approaches to antibacterial prophylaxis after prostate biopsy differ only depending on the type of biopsy access.
- 25 September 2021
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 14 (3)
Open AccessOptions for antibacterial prophylaxis of infectious complications of prostate biopsy
Introduction. Amount of prostate biopsy procedures rises every year and up to 95% of cases of prostate biopsy is performed via transrectal approach. The incidence of infectious complications of transrectal prostate biopsy reaches up to 17%, while incidence of such complications of transperineal biopsy is about 1%. The majority of international clinical guidelines recommends for obligatory antibiotic prophylaxis prior to prostate biopsy of any approach, but the choice of antibiotic is still debatable. The aim of this review is to sum up the approaches of international urological guidelines to the antibiotic prophylaxis prior to prostate biopsy. Materials and methods. We analyzed the search results in the scientific databases PubMed, Google Scolar, elibrary.ru for the queries «prostate biopsy», «antibacterial prophylaxis» and «guidelines». Results. According to the recommendations of most professional communities, antibacterial prophylaxis of infectious complications of prostate biopsy can be carried out in various ways - once or for a long time, one- or two-component, empirically or on the basis of urine culture on microflora. Conclusion. Despite the differences in the levels of sensitivity and resistance of coliform flora around the world, the clinical guidelines in most countries are uniform in terms of the choice of drugs to reduce the risk of developing infectious complications after prostate biopsy. Approaches to antibacterial prophylaxis after prostate biopsy differ only depending on the type of biopsy access.
- Open Access
- 25 July 2021
- Published by Publishing House ABV Press in Cancer Urology
- Vol. 17 (2) , 46-52
The first experience of transperineal prostate biopsy without antibiotic prophylaxis
Objective: to study the safety of omitting the antibiotic prophylaxis before transperineal prostate biopsy.Materials and methods. The prospective randomized study included data, obtained during the diagnostical process of 85 patients, who underwent transperineal prostate biopsy in 2020. In the control group (n = 50) patients received 1 g Ceftriaxone IV 1 h before the biopsy. In the study group (n = 35) biopsy was performed without previous antibacterial prophylaxis. Age median was 63.2 (52-75) years.Results. No significant differences in the infection complications rate (UTI, soft tissues infections, prostatitis, fever, sepsis) were obtained between the groups. No patient developed UTI, prostatitis or sepsis, confirmed with urine culture.Conclusion. Performing transperineal prostate biopsy without antibiotic prophylaxis seems to be a safe alternative to common prophylaxis regiments, dedicated to infection complications prevention after prostate biopsy.
- 25 July 2021
- Published by Publishing House ABV Press in Cancer Urology
- Vol. 17 (2) , 46-52
Open AccessThe first experience of transperineal prostate biopsy without antibiotic prophylaxis
Objective: to study the safety of omitting the antibiotic prophylaxis before transperineal prostate biopsy.Materials and methods. The prospective randomized study included data, obtained during the diagnostical process of 85 patients, who underwent transperineal prostate biopsy in 2020. In the control group (n = 50) patients received 1 g Ceftriaxone IV 1 h before the biopsy. In the study group (n = 35) biopsy was performed without previous antibacterial prophylaxis. Age median was 63.2 (52-75) years.Results. No significant differences in the infection complications rate (UTI, soft tissues infections, prostatitis, fever, sepsis) were obtained between the groups. No patient developed UTI, prostatitis or sepsis, confirmed with urine culture.Conclusion. Performing transperineal prostate biopsy without antibiotic prophylaxis seems to be a safe alternative to common prophylaxis regiments, dedicated to infection complications prevention after prostate biopsy.
- Open Access
- 5 May 2021
- Published by Publishing House ABV Press in Cancer Urology
- Vol. 17 (1) , 153-158-158
Modern aspects of targeted prostate biopsy
Prostate cancer (PCa) is in second place in oncological morbidity in males and is the fifth leading cause of death among the world's population. According to current world statistics, over the past 20 years there has been an increase in primary morbidity, as well as mortality from PCa. The key to diagnosing PCa is a prostate biopsy. Nevertheless, a systemic biopsy under transrectal ultrasound control is the subject of discussion and debate in oncourology, as it has significant drawbacks that affect the qualitative result of the diagnosis of PCa. Given the importance of adequate and staged PCa, various methods of targeted biopsy under magnetic resonance control have been proposed.This review will examine the main features and significance of targeted prostate biopsy, as well as the role of magnetic resonance imaging in the early diagnosis of PCa. The method of targeted biopsy of the prostate gland can improve the detection of PCa in relation to clinically significant forms. In addition, this method is extremely promising and requires further study to further improve the quality of early diagnosis of PCa, especially when selecting patients for radical surgical treatment.
- 5 May 2021
- Published by Publishing House ABV Press in Cancer Urology
- Vol. 17 (1) , 153-158-158
Open AccessModern aspects of targeted prostate biopsy
Prostate cancer (PCa) is in second place in oncological morbidity in males and is the fifth leading cause of death among the world's population. According to current world statistics, over the past 20 years there has been an increase in primary morbidity, as well as mortality from PCa. The key to diagnosing PCa is a prostate biopsy. Nevertheless, a systemic biopsy under transrectal ultrasound control is the subject of discussion and debate in oncourology, as it has significant drawbacks that affect the qualitative result of the diagnosis of PCa. Given the importance of adequate and staged PCa, various methods of targeted biopsy under magnetic resonance control have been proposed.This review will examine the main features and significance of targeted prostate biopsy, as well as the role of magnetic resonance imaging in the early diagnosis of PCa. The method of targeted biopsy of the prostate gland can improve the detection of PCa in relation to clinically significant forms. In addition, this method is extremely promising and requires further study to further improve the quality of early diagnosis of PCa, especially when selecting patients for radical surgical treatment.
- Open Access
- 25 March 2021
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 14 (1)
Bladder neck stenosis after surgical treatment of patients with benign prostatic hyperplasia. Epidemiology. Modern treatment options
Introduction. With the development of modern technologies and treatment methods of benign prostatic hyperplasia (BPH), there is an increase in the number of operations performed for this disease. In this regard, the absolute number of complications is also growing. Bladder neck stenosis (BNS) is one of those complications. The purpose of this review is to update information about currently available methods of treatment of BNS and their effectiveness. Materials and methods. 352 articles from the PubMed database, the scientific electronic library elibrary.ru and the websites of professional urological associations were analyzed. After processing the data, 37 articles and one practical guide were selected for the review. Results. Chronic diseases that contribute to the violation of microcirculation in the area of bladder neck (BN) (diabetes mellitus, atherosclerosis), smoking are predisposing factors for the development of BNS. A small volume of the prostate (less than 30 ml) is an independent risk factor and requires special attention when choosing a treatment method for patients with BPH. The amount of thermal exposure to the BN area during surgery affects the degree of microcirculation disturbance and, accordingly, the risk of BNS. Endoscopic methods of correction of BNS have moderate effectiveness in its primary occurrence and low effectiveness in recurrent cases. Reconstructive methods of correction of BNS shown to be highly effective in recurrent cases. Conclusion. Etiopathogenesis of BNS is multifactorial and depends on endogenous and exogenous factors. Treatment options for BNS range from simple outpatient procedures to complex reconstructive interventions. Each of the treatment methods should be considered individually for each patient, taking into account the characteristics of the patient’s history.
- 25 March 2021
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 14 (1)
Open AccessBladder neck stenosis after surgical treatment of patients with benign prostatic hyperplasia. Epidemiology. Modern treatment options
Introduction. With the development of modern technologies and treatment methods of benign prostatic hyperplasia (BPH), there is an increase in the number of operations performed for this disease. In this regard, the absolute number of complications is also growing. Bladder neck stenosis (BNS) is one of those complications. The purpose of this review is to update information about currently available methods of treatment of BNS and their effectiveness. Materials and methods. 352 articles from the PubMed database, the scientific electronic library elibrary.ru and the websites of professional urological associations were analyzed. After processing the data, 37 articles and one practical guide were selected for the review. Results. Chronic diseases that contribute to the violation of microcirculation in the area of bladder neck (BN) (diabetes mellitus, atherosclerosis), smoking are predisposing factors for the development of BNS. A small volume of the prostate (less than 30 ml) is an independent risk factor and requires special attention when choosing a treatment method for patients with BPH. The amount of thermal exposure to the BN area during surgery affects the degree of microcirculation disturbance and, accordingly, the risk of BNS. Endoscopic methods of correction of BNS have moderate effectiveness in its primary occurrence and low effectiveness in recurrent cases. Reconstructive methods of correction of BNS shown to be highly effective in recurrent cases. Conclusion. Etiopathogenesis of BNS is multifactorial and depends on endogenous and exogenous factors. Treatment options for BNS range from simple outpatient procedures to complex reconstructive interventions. Each of the treatment methods should be considered individually for each patient, taking into account the characteristics of the patient’s history.
- Open Access
- 1 January 2021
- Published by Taylor & Francis in Research and Reports in Urology
- Vol. 13, 335-340
Cystic Prostatic Carcinoma - A Clinical Case and Literature Review
Cystic formations in the prostate are quite common, but the vast majority are benign. The cystic form of prostate adenocarcinoma can present unexpected symptoms, and management can be difficult because of the local advanced stage of the disease. A unique feature of this case is the surgical local cancer treatment. In this clinical case, we describe the literature surrounding this rare form of neoplasm. We present a clinical case of a rare form of prostate cancer in a 71-year-old male who was admitted to ER with acute urinary retention. A huge obstructing prostatic cyst was revealed. After successful trial-without-catheter, the patient underwent transperineal cyst draining and this restored urination. PSAt was increased up to 55 ng/mL. The cystic wall biopsy revealed adenocarcinoma with a Gleason score of 8 (4+4) (Gleason Group IV), and distant metastasis was noticed with PSMA PET/CT. The patient started androgen deprivation therapy (ADT) with excellent PSA dynamics in three months. Because of lower urinary tract symptoms, he needed local treatment and underwent radical prostatectomy. A three-month follow-up demonstrated a common post-operative period, mild stress incontinence, and PSAt 0.004 ng/mL. Cystic prostatic carcinoma can manifest as urinary retention and be mistakenly taken for a benign obstructing prostate cyst. Despite the locally advanced tumor, it can be successfully treated locally in highly selected patients.
- 1 January 2021
- Published by Taylor & Francis in Research and Reports in Urology
- Vol. 13, 335-340
Open AccessCystic Prostatic Carcinoma - A Clinical Case and Literature Review
Cystic formations in the prostate are quite common, but the vast majority are benign. The cystic form of prostate adenocarcinoma can present unexpected symptoms, and management can be difficult because of the local advanced stage of the disease. A unique feature of this case is the surgical local cancer treatment. In this clinical case, we describe the literature surrounding this rare form of neoplasm. We present a clinical case of a rare form of prostate cancer in a 71-year-old male who was admitted to ER with acute urinary retention. A huge obstructing prostatic cyst was revealed. After successful trial-without-catheter, the patient underwent transperineal cyst draining and this restored urination. PSAt was increased up to 55 ng/mL. The cystic wall biopsy revealed adenocarcinoma with a Gleason score of 8 (4+4) (Gleason Group IV), and distant metastasis was noticed with PSMA PET/CT. The patient started androgen deprivation therapy (ADT) with excellent PSA dynamics in three months. Because of lower urinary tract symptoms, he needed local treatment and underwent radical prostatectomy. A three-month follow-up demonstrated a common post-operative period, mild stress incontinence, and PSAt 0.004 ng/mL. Cystic prostatic carcinoma can manifest as urinary retention and be mistakenly taken for a benign obstructing prostate cyst. Despite the locally advanced tumor, it can be successfully treated locally in highly selected patients.
- Open Access
- 1 January 2021
- Published by Medknow in Urology Annals
- Vol. 13 (2) , 194-197
Urethral leiomyoma: A rare neoplasm
Extrauterine leiomyoma is a rare benign tumor, originating from smooth muscle cells, most often localized in the uterus. Extrauterine localization of leiomyoma is extremely rare. The presence of a neoplasm near the urethra always poses a challenge for differential diagnosis. Variety of pathologies sharing similar clinical findings requires further diagnostic testing and doctor alertness. We present the clinical case of urethral leiomyoma in a female patient aged 42 years complaining of frequent urination and vulval mass. The patient underwent neoplasm removal with further histologic examination revealing urethral leiomyoma. The article features the diagnosis and treatment of this rare pathology.
- 1 January 2021
- Published by Medknow in Urology Annals
- Vol. 13 (2) , 194-197
Open AccessUrethral leiomyoma: A rare neoplasm
Extrauterine leiomyoma is a rare benign tumor, originating from smooth muscle cells, most often localized in the uterus. Extrauterine localization of leiomyoma is extremely rare. The presence of a neoplasm near the urethra always poses a challenge for differential diagnosis. Variety of pathologies sharing similar clinical findings requires further diagnostic testing and doctor alertness. We present the clinical case of urethral leiomyoma in a female patient aged 42 years complaining of frequent urination and vulval mass. The patient underwent neoplasm removal with further histologic examination revealing urethral leiomyoma. The article features the diagnosis and treatment of this rare pathology.